Longeveron IncChange company Symbol lookupSelect an option...LGVN Longeveron IncGSIT GSI Technology IncGME GameStop CorpCMBM Cambium Networks CorpS SentinelOne IncBAC Bank of America CorpSDA SunCar Technology Group IncRAIN Rain Oncology IncEOI Eaton Vance Enhanced Equity Income FundOLNCF Omni Lite Industries Canada IncGo
Longeveron Inc. is a clinical-stage biotechnology company, which is developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. The Company is primarily focused on three pipeline indications, such as aging related frailty, Alzheimer's disease (AD), acute respiratory distress syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). Its Lomecel-B has multiple mechanisms of action encompassing pro-vascular, pro-regenerative, anti- inflammatory, and tissue repair and healing effects with potential applications across a spectrum of disease areas. The Company has bone marrow supply contracts in with two suppliers: the Oklahoma Blood Institute and Vista Health Research.
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| May 12, 2023 | Q1 2023 Earnings Release | -$0.22 | -$0.23 to -$0.19 | -$0.17 |
| March 10, 2023 | Q4 2022 Earnings Release | -$0.21 | -$0.25 to -$0.10 | -$0.20 |
| November 14, 2022 | Q3 2022 Earnings Release | -$0.25 | -$0.24 to -$0.20 | -- |
| August 12, 2022 | Q2 2022 Earnings Release | -$0.27 | -$0.26 to -$0.19 | -- |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
, , , Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.